EUVIMEDEUVIMED entdecken
Crossref

d-mannose targets PD-1 to lysosomal degradation and enhances T cell-mediated anti-tumor immunity

Wenjing Dong, Mingen Lin, Ruonan Zhang, Xue Sun, Hongchen Li, Tianshu Liu, Yanping Xu, Lei Lv

Cancer Letters · 2024

DOI: 10.1016/j.canlet.2024.216883 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von Wenjing Dong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ministry of Education Key Laboratory of Metabolism and Molecular Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical …. Hauptthemen laut MEDLINE: Programmed Cell Death 1 Receptor, Lysosomes, T-Lymphocytes, Mannose. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High expression of programmed cell death protein 1 (PD-1), a typical immune checkpoint, results in dysfunction of T cells in tumor microenvironment. Antibodies and inhibitors against PD-1 or its ligand (PD-L1) have been widely used in various malignant tumors. However, the mechanisms by which PD-1 is regulated are not fully understood. Here, we report a mechanism of PD-1 degradation triggered by d-mannose and the universality of this mechanism in anti-tumor immunity. We show that d-mannose inactivates GSK3β via promoting phosphorylation of GSK3β at Ser9, thereby leading to TFE3 translocation to nucleus and subsequent PD-1 proteolysis induced by enhanced lysosome biogenesis. Notably, combination of d-mannose and PD-1 blockade exhibits remarkable tumor growth suppression attributed to elevated cytotoxicity activity of T cells in vivo. Furthermore, d-mannose treatment dramatically improves the therapeutic efficacy of MEK inhibitor (MEKi) trametinib in vivo. Our findings unveil a universally unrecognized anti-tumor mechanism of d-mannose by destabilizing PD-1 and provide strategies to enhance the efficacy of both immune checkpoint blockade (ICB) and MEKi -based therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Programmed Cell Death 1 ReceptorLysosomesT-LymphocytesMannoseAnimalsHumansMiceCell Line, TumorTumor MicroenvironmentImmune Checkpoint InhibitorsGlycogen Synthase Kinase 3 betaPyrimidinonesPhosphorylationPyridonesBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsMice, Inbred C57BLProteolysisNeoplasms

Stichwörter der Autor:innen

Lysosomal degradationMEKiPD-1TFE3Tumor immunityd-mannose

Substanzen

Programmed Cell Death 1 ReceptorMannoseImmune Checkpoint InhibitorsGlycogen Synthase Kinase 3 betaPyrimidinonesPyridonesBasic Helix-Loop-Helix Leucine Zipper Transcription Factors

Autor:innen und Institutionen

  • Ministry of Education Key Laboratory of Metabolism and Molecular Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Zhongshan Hospital, Fudan University, Shanghai, 200032, Chin…
  • Tongji Hospital, Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China.
  • Dept of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. Electronic address: liu.tianshu@zs-hospital.sh.cn.
  • Tongji Hospital, Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China. Electronic…

Förderung

  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Dong, W., Lin, M., Zhang, R., Sun, X., Li, H., Liu, T., Xu, Y., & Lv, L. (2024). d-mannose targets PD-1 to lysosomal degradation and enhances T cell-mediated anti-tumor immunity. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.216883

Vancouver

Dong W, Lin M, Zhang R, Sun X, Li H, Liu T, et al. d-mannose targets PD-1 to lysosomal degradation and enhances T cell-mediated anti-tumor immunity. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.216883

BibTeX
@article{Dong2024,
  author = {Dong, Wenjing and Lin, Mingen and Zhang, Ruonan and Sun, Xue and Li, Hongchen and Liu, Tianshu and Xu, Yanping and Lv, Lei},
  title = {d-mannose targets PD-1 to lysosomal degradation and enhances T cell-mediated anti-tumor immunity},
  journal = {Cancer Letters},
  year = {2024},
  doi = {10.1016/j.canlet.2024.216883}
}
Kostenlos starten →